Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EXPO Stock Forecast 2026-2027
$59.66
Current Price
$2.89B
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to EXPO Price Targets
+50.9%
To High Target of $90.00
+34.1%
To Median Target of $80.00
+25.7%
To Low Target of $75.00
EXPO Price Momentum
-1.2%
1 Week Change
-2.9%
1 Month Change
-22.9%
1 Year Change
-14.1%
Year-to-Date Change
-27.2%
From 52W High of $81.95
+14.9%
From 52W Low of $51.91
📊 TOP ANALYST CALLS
Did EXPO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Exponent is one of their latest high-conviction picks.
Latest EXPO Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, EXPO has a bullish consensus with a median price target of $80.00 (ranging from $75.00 to $90.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $59.66, the median forecast implies a 34.1% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EXPO Analyst Ratings
3
Buy
1
Hold
0
Sell
EXPO Price Target Range
Low
$75.00
Average
$80.00
High
$90.00
Current: $59.66
Latest EXPO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EXPO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 15, 2026 | JP Morgan | Tomohiko Sano | Overweight | Maintains | $80.00 |
| May 1, 2026 | UBS | Neutral | Maintains | $N/A | |
| Mar 26, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| Jan 26, 2026 | JP Morgan | Overweight | Initiates | $N/A | |
| Dec 15, 2025 | UBS | Neutral | Maintains | $N/A | |
| Nov 17, 2025 | William Blair | Outperform | Upgrade | $N/A | |
| Jul 26, 2024 | Truist Securities | Buy | Reiterates | $N/A | |
| Apr 29, 2024 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 2, 2024 | Truist Securities | Buy | Maintains | $N/A | |
| Jul 31, 2023 | Truist Securities | Buy | Maintains | $N/A | |
| Jun 1, 2023 | UBS | Neutral | Initiates | $N/A | |
| Apr 5, 2022 | Truist Securities | Buy | Maintains | $N/A | |
| Aug 2, 2021 | Truist Securities | Buy | Maintains | $N/A | |
| Jun 2, 2020 | Sidoti & Co. | Buy | Maintains | $N/A | |
| May 13, 2020 | Sidoti & Co. | Buy | Upgrade | $N/A | |
| May 1, 2020 | Sidoti & Co. | Neutral | Maintains | $N/A | |
| Mar 19, 2020 | Sidoti & Co. | Buy | Upgrade | $N/A | |
| Feb 7, 2020 | Sidoti & Co. | Neutral | Maintains | $N/A | |
| Oct 3, 2019 | Sidoti & Co. | Neutral | Maintains | $N/A | |
| Sep 20, 2019 | SunTrust Robinson Humphrey | Buy | Maintains | $N/A |
Exponent Inc. (EXPO) Competitors
The following stocks are similar to Exponent based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Exponent Inc. (EXPO) Financial Data
Exponent Inc. has a market capitalization of $2.89B with a P/E ratio of 27.9x. The company generates $551.14M in trailing twelve-month revenue with a 19.8% profit margin.
Revenue growth is +10.5% quarter-over-quarter, while maintaining an operating margin of +27.3% and return on equity of +27.9%.
Valuation Metrics
Market Cap
$2.89B
Enterprise Value
$2.86B
P/E Ratio
27.9x
PEG Ratio
2.1x
Price/Sales
5.3x
Growth & Margins
Revenue Growth (YoY)
+10.5%
Gross Margin
N/A
Operating Margin
+27.3%
Net Margin
+19.8%
EPS Growth
+11.0%
Financial Health
Cash/Price Ratio
+4.1%
Current Ratio
2.4x
Debt/Equity
24.0x
ROE
+27.9%
ROA
+10.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Exponent Inc. (EXPO) Business Model
About Exponent Inc.
What They Do
Provides consulting in engineering and scientific investigations.
Business Model
Exponent Inc. operates as a consulting firm that generates revenue by offering comprehensive analysis and solutions for complex issues in various sectors including infrastructure, energy, and environmental services. The company leverages a multidisciplinary approach, employing experts across different fields to provide reliable investigations and recommendations for businesses, industries, and government agencies.
Additional Information
Founded in 1967, Exponent has established a significant market presence, serving an extensive portfolio of clients including Fortune 500 companies, law firms, and governmental bodies. The firm's focus on innovation and compliance with safety standards positions it as a leader in knowledge-based consulting services, helping clients optimize performance and navigate regulatory challenges.
Company Information
Sector
Industrials
Industry
Engineering & Construction
Employees
976
CEO
Dr. Catherine Ford Corrigan P.E., Ph.D.
Country
United States
IPO Year
1990
Website
www.exponent.comExponent Inc. (EXPO) Latest News & Analysis
Latest News
Quick Summary
Exponent, Inc. (Nasdaq: EXPO) executives will participate in a fireside chat at an upcoming investor conference, enhancing investor engagement and communication.
Why It Matters
Leadership participation in investor conferences can signal strategic insights and company transparency, potentially influencing stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Exponent (EXPO) has a strong balance sheet and a 13-year dividend growth streak. Fiscal 2026 outlook shows expected revenue growth, with shares trading at $65, below the fair value of $73.80.
Why It Matters
Exponent's strong dividend track record, robust balance sheet, and positive fiscal outlook amid AI demand indicate growth potential. The stock's undervaluation suggests a buying opportunity for investors.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Exponent, Inc. (EXPO) held its Q1 2026 earnings call, discussing financial performance and strategic initiatives. Further details can be found in the full transcript.
Why It Matters
The Q1 2026 earnings call provides insights into Exponent, Inc.'s financial performance and future guidance, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Exponent, Inc. (Nasdaq: EXPO) declared a quarterly cash dividend of $0.31 per share, payable on June 18, 2026, to stockholders of record as of June 5, 2026.
Why It Matters
Exponent's dividend announcement signals financial stability and a commitment to returning value to shareholders, potentially attracting income-focused investors and boosting stock demand.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Exponent, Inc. (Nasdaq: EXPO) announced its financial results for Q1 of FY 2026, ending April 3, 2026. Further details on performance were not provided in the excerpt.
Why It Matters
Exponent, Inc.'s Q1 financial results can influence stock performance and investor sentiment, impacting share price and future growth expectations.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Exponent (EXPO) reported Q3 earnings of $0.59 per share, surpassing the Zacks estimate of $0.56 and up from $0.52 per share year-over-year.
Why It Matters
Exponent's earnings beat expectations and show year-over-year growth, indicating strong financial performance and potentially boosting investor confidence and stock value.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About EXPO Stock
What is Exponent Inc.'s (EXPO) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Exponent Inc. (EXPO) has a median price target of $80.00. The highest price target is $90.00 and the lowest is $75.00.
Is EXPO stock a good investment in 2026?
According to current analyst ratings, EXPO has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $59.66. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EXPO stock?
Wall Street analysts predict EXPO stock could reach $80.00 in the next 12 months. This represents a 34.1% increase from the current price of $59.66. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Exponent Inc.'s business model?
Exponent Inc. operates as a consulting firm that generates revenue by offering comprehensive analysis and solutions for complex issues in various sectors including infrastructure, energy, and environmental services. The company leverages a multidisciplinary approach, employing experts across different fields to provide reliable investigations and recommendations for businesses, industries, and government agencies.
What is the highest forecasted price for EXPO Exponent Inc.?
The highest price target for EXPO is $90.00 from at , which represents a 50.9% increase from the current price of $59.66.
What is the lowest forecasted price for EXPO Exponent Inc.?
The lowest price target for EXPO is $75.00 from at , which represents a 25.7% increase from the current price of $59.66.
What is the overall EXPO consensus from analysts for Exponent Inc.?
The overall analyst consensus for EXPO is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $80.00.
How accurate are EXPO stock price projections?
Stock price projections, including those for Exponent Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 8, 2026 8:58 AM UTC